These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31256114)

  • 1. Inflammatory breast cancer: A review from our experience.
    Mele M; Sørensen AS; Bruun J; Funder JA; Tramm T; Bodilsen A; Nielsen HM; Christiansen PM
    Breast Dis; 2019; 38(2):47-55. PubMed ID: 31256114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
    Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
    Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
    Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory breast cancer in the Netherlands; improved survival over the last decades.
    van Uden DJ; Bretveld R; Siesling S; de Wilt JH; Blanken-Peeters CF
    Breast Cancer Res Treat; 2017 Apr; 162(2):365-374. PubMed ID: 28138891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory breast cancer: a single centre analysis.
    Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
    Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
    Diessner J; Van Ewijk R; Weiss CR; Janni W; Wischnewsky MB; Kreienberg R; Hancke K; Blettner M; Wöckel A; Schwentner L
    Arch Gynecol Obstet; 2015 Sep; 292(3):655-64. PubMed ID: 25814296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.
    Kai M; Kogawa T; Liu DD; Fouad TM; Kai K; Niikura N; Hsu L; Willey JS; Theriault RL; Valero V; Ueno NT
    Clin Breast Cancer; 2015 Feb; 15(1):37-42. PubMed ID: 25258308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MARCKS protein overexpression in inflammatory breast cancer.
    Manai M; Thomassin-Piana J; Gamoudi A; Finetti P; Lopez M; Eghozzi R; Ayadi S; Lamine OB; Manai M; Rahal K; Charafe-Jauffret E; Jacquemier J; Viens P; Birnbaum D; Boussen H; Chaffanet M; Bertucci F
    Oncotarget; 2017 Jan; 8(4):6246-6257. PubMed ID: 28009981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
    Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
    Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes in patients with inflammatory breast cancer; a single center experience.
    Kertmen N; Babacan T; Keskin O; Solak M; Sarici F; Akin S; Arik Z; Aslan A; Ates O; Aksoy S; Ozisik Y; Altundag K
    J BUON; 2015; 20(1):35-9. PubMed ID: 25778293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].
    Benbrahim Z; Berrada A; Amaadour L; Zahra El M'rabet F; Elfatemi H; Elfakir S; Mellas N; Arifi S
    Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):604-608. PubMed ID: 29100820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
    Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
    Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.
    Liu J; Chen K; Jiang W; Mao K; Li S; Kim MJ; Liu Q; Jacobs LK
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):161-168. PubMed ID: 27704268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients.
    Weiss A; Menen RS; Lin HY; Shen Y; Rosso KJ; Shaitelman S; Woodward W; Valero V; Ueno NT; Bedrosian I; Babiera G
    Breast Cancer Res Treat; 2018 Jun; 169(3):615-623. PubMed ID: 29460033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review.
    Copson E; Shaaban AM; Maishman T; Moseley PM; McKenzie H; Bradbury J; Borley A; Brzezinska M; Chan SYT; Ching J; Cutress RI; Danial I; Dall B; Kerin M; Lowery AJ; Macpherson IR; Romics L; Sawyer E; Sharmat N; Sircar T; Vidya R; Pan Y; Rea D; Jones L; Eccles DM; Berditchevski F
    Breast; 2018 Dec; 42():133-141. PubMed ID: 30278369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
    Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Pfeiffer RM; Gadalla SM; Swain SM; Merajver SD; Brown LM; Soliman AS
    Breast Cancer Res Treat; 2019 Jul; 176(2):407-417. PubMed ID: 31006821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
    Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
    Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer.
    Sawaki M; Ito Y; Akiyama F; Tokudome N; Horii R; Mizunuma N; Takahashi S; Horikoshi N; Imai T; Nakao A; Kasumi F; Sakamoto G; Hatake K
    Breast Cancer; 2006; 13(2):172-8. PubMed ID: 16755113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells in newly diagnosed inflammatory breast cancer.
    Mego M; Giordano A; De Giorgi U; Masuda H; Hsu L; Giuliano M; Fouad TM; Dawood S; Ueno NT; Valero V; Andreopoulou E; Alvarez RH; Woodward WA; Hortobagyi GN; Cristofanilli M; Reuben JM
    Breast Cancer Res; 2015 Jan; 17(1):2. PubMed ID: 25572591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.
    Chaher N; Arias-Pulido H; Terki N; Qualls C; Bouzid K; Verschraegen C; Wallace AM; Royce M
    Breast Cancer Res Treat; 2012 Jan; 131(2):437-44. PubMed ID: 21360074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.